Sétha Douc‐Rasy

1.6k total citations
38 papers, 1.4k citations indexed

About

Sétha Douc‐Rasy is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Sétha Douc‐Rasy has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Neurology and 13 papers in Oncology. Recurrent topics in Sétha Douc‐Rasy's work include Neuroblastoma Research and Treatments (16 papers), Cancer-related Molecular Pathways (10 papers) and Cancer therapeutics and mechanisms (9 papers). Sétha Douc‐Rasy is often cited by papers focused on Neuroblastoma Research and Treatments (16 papers), Cancer-related Molecular Pathways (10 papers) and Cancer therapeutics and mechanisms (9 papers). Sétha Douc‐Rasy collaborates with scholars based in France, United States and Morocco. Sétha Douc‐Rasy's co-authors include Jean Bénard, G Riou, Jean‐Charles Ahomadegbe, Michel Barrois, Sandy Fogel, J.C. Ahomadegbe, David Goldschneider, P. Armand, Pierre Duvillard and Dominique Valteau‐Couanet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Experimental Medicine.

In The Last Decade

Sétha Douc‐Rasy

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sétha Douc‐Rasy France 20 987 528 296 166 128 38 1.4k
Yoshinori Nimura Japan 19 824 0.8× 713 1.4× 219 0.7× 77 0.5× 127 1.0× 36 1.3k
A. Bianchi United States 15 468 0.5× 284 0.5× 151 0.5× 228 1.4× 72 0.6× 22 1.1k
Alexandre Valent France 5 1.2k 1.2× 1.2k 2.3× 233 0.8× 102 0.6× 140 1.1× 7 1.7k
Camilla L. Christensen Denmark 19 795 0.8× 600 1.1× 184 0.6× 82 0.5× 119 0.9× 34 1.4k
S Mathew United States 16 553 0.6× 385 0.7× 146 0.5× 65 0.4× 213 1.7× 32 1.1k
Philippe Pujuguet Belgium 16 542 0.5× 446 0.8× 153 0.5× 59 0.4× 71 0.6× 22 1.1k
Shu Fen Wen United States 15 857 0.9× 626 1.2× 130 0.4× 22 0.1× 466 3.6× 18 1.3k
Laura R. Livingstone United States 6 1.0k 1.0× 852 1.6× 297 1.0× 14 0.1× 154 1.2× 8 1.4k
Alan W. Lau United States 19 1.5k 1.5× 638 1.2× 211 0.7× 41 0.2× 93 0.7× 20 2.1k
Abdellatif Errami Netherlands 18 1.2k 1.2× 320 0.6× 374 1.3× 42 0.3× 358 2.8× 23 1.5k

Countries citing papers authored by Sétha Douc‐Rasy

Since Specialization
Citations

This map shows the geographic impact of Sétha Douc‐Rasy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sétha Douc‐Rasy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sétha Douc‐Rasy more than expected).

Fields of papers citing papers by Sétha Douc‐Rasy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sétha Douc‐Rasy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sétha Douc‐Rasy. The network helps show where Sétha Douc‐Rasy may publish in the future.

Co-authorship network of co-authors of Sétha Douc‐Rasy

This figure shows the co-authorship network connecting the top 25 collaborators of Sétha Douc‐Rasy. A scholar is included among the top collaborators of Sétha Douc‐Rasy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sétha Douc‐Rasy. Sétha Douc‐Rasy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gattolliat, Charles‐Henry, Frédéric Pendino, Josette Hillion, et al.. (2012). Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant. Molecular Cancer Therapeutics. 11(11). 2384–2393. 13 indexed citations
2.
Thomas, Laurent F., Silvia Anna Ciafrè, Guillaume Meurice, et al.. (2011). Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. British Journal of Cancer. 105(9). 1352–1361. 88 indexed citations
3.
Bettayeb, Karima, Nadège Loaëc, Alison J. Hole, et al.. (2010). CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells. Genes & Cancer. 1(4). 369–380. 68 indexed citations
4.
Goldschneider, David, et al.. (2008). p73α isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells. Nucleic Acids Research. 36(13). 4222–4232. 32 indexed citations
5.
Blanc, Étienne, David Goldschneider, Sétha Douc‐Rasy, Jean Bénard, & Gilda Raguénez. (2005). Wnt-5a gene expression in malignant human neuroblasts. Cancer Letters. 228(1-2). 117–123. 33 indexed citations
6.
Goldschneider, David, Karine Million, Anne Meiller, et al.. (2005). The neurogene BTG2TIS21/PC3 is transactivated by ΔNp73α via p53 specifically in neuroblastoma cells. Journal of Cell Science. 118(6). 1245–1253. 16 indexed citations
7.
Douc‐Rasy, Sétha, David Goldschneider, Karine Million, & Jean Bénard. (2004). Interactivité entre p73 et p53 dans les cancers : un modèle, le neuroblastome. médecine/sciences. 20(3). 317–324. 4 indexed citations
8.
Bénard, Jean, Sétha Douc‐Rasy, & Jean‐Charles Ahomadegbe. (2003). TP53 family members and human cancers. Human Mutation. 21(3). 182–191. 173 indexed citations
9.
Goldschneider, David, Étienne Blanc, Gilda Raguénez, et al.. (2003). When p53 needs p73 to be functional – forced p73 expression induces nuclear accumulation of endogenous p53 protein. Cancer Letters. 197(1-2). 99–103. 10 indexed citations
10.
Blanc, Étienne, David Goldschneider, Eric Ferrandis, et al.. (2003). MYCN Enhances P-gp/MDR1 Gene Expression in the Human Metastatic Neuroblastoma IGR-N-91 Model. American Journal Of Pathology. 163(1). 321–331. 34 indexed citations
11.
Douc‐Rasy, Sétha, Michel Barrois, Mourad Kaghad, et al.. (2002). ΔN-p73α Accumulates in Human Neuroblastic Tumors. American Journal Of Pathology. 160(2). 631–639. 49 indexed citations
12.
Barrois, Michel, et al.. (2001). Genomic and allelic expression status of thep73 gene in human neuroblastoma. Medical and Pediatric Oncology. 36(1). 45–47. 4 indexed citations
13.
Raguénez, Gilda, Sétha Douc‐Rasy, Étienne Blanc, et al.. (2001). [A functional gene map is required to adapt therapy of metastatic neuroblastoma].. PubMed. 88(3). 295–304. 3 indexed citations
14.
Marangoni, Elisabetta, Muriel Le Romancer, Nicolas Foray, et al.. (2000). Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts. Cancer Gene Therapy. 7(2). 339–346. 39 indexed citations
15.
16.
Duband‐Goulet, Isabelle, et al.. (1992). Chromatin reconstitution on small DNA rings. Journal of Molecular Biology. 224(4). 981–1001. 37 indexed citations
17.
18.
Douc‐Rasy, Sétha, Jean‐François Riou, Jean‐Charles Ahomadegbe, & G Riou. (1988). ATP‐independent DNA topoisomerase II as potential drug target in trypanosomes. Biology of the Cell. 64(2). 145–156. 11 indexed citations
19.
Douc‐Rasy, Sétha, et al.. (1986). [A DNA topoisomerase from trypanosomes able to catenate, decatenate and unknot DNA without ATP].. PubMed. 302(8). 283–6. 1 indexed citations
20.
Douc‐Rasy, Sétha, et al.. (1983). A specific inhibitor of type I DNA-topoisomerase of Trypanosoma cruzi: Dimethyl-hydroxy-ellipticinium. Biochemical and Biophysical Research Communications. 117(1). 1–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshinori Nimura Breakdown of academic impact, for papers by A. Bianchi Breakdown of academic impact, for papers by Alexandre Valent Breakdown of academic impact, for papers by Camilla L. Christensen Breakdown of academic impact, for papers by S Mathew Breakdown of academic impact, for papers by Philippe Pujuguet Breakdown of academic impact, for papers by Shu Fen Wen Breakdown of academic impact, for papers by Laura R. Livingstone Breakdown of academic impact, for papers by Alan W. Lau Breakdown of academic impact, for papers by Abdellatif Errami
Rankless by CCL
2026